Raj K. Puri
Fortune : 2 M $ au 31/08/2026
Fortune : 2 M $ au 31/08/2026
Dr. Raj K.
Puri is a Chief Regulatory Officer at Iovance Biotherapeutics, Inc. Dr. Puri was previously employed as a Director-Division Cellular by Center for Biologics Evaluation & Research.
He received his doctorate degree from Universidad Autónoma de Ciudad Juárez.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 08/09/2026 | 256 364 ( 0,06 % ) | 2 M $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Conseiller Juridique Général | 26/11/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
Center for Biologics Evaluation & Research
Center for Biologics Evaluation & Research Miscellaneous Commercial ServicesCommercial Services Engages in conducting research to promote safe and appropriate use of biological products | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
Universidad Autónoma de Ciudad Juárez
Universidad Autónoma de Ciudad Juárez Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
Center for Biologics Evaluation & Research
Center for Biologics Evaluation & Research Miscellaneous Commercial ServicesCommercial Services Engages in conducting research to promote safe and appropriate use of biological products | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national